[Treatment of osteoporosis with estrogen].
Mizunuma
Hideki
H
Department of Obstetrics & Gynecology, Hirosaki University School of Medicine.
D015519:Bone Density; D001943:Breast Neoplasms / Q000209:etiology; D016889:Endometrial Neoplasms / Q000209:etiology; D004964:Estriol / Q000008:administration & dosage / Q000009:adverse effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology; D012306:Risk
D004966:Estrogens, Conjugated (USP); D008656:Mestranol; D004964:Estriol